文献速递慢性肾脏病遗传性与小管间质肾病

镰状细胞特质相关血浆代谢物改变及其与肾衰竭风险的关系

Alterations of Plasma Metabolites Associated with Sickle Cell Trait.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-02-27

在986名老年黑人女性SCT携带者与998名匹配对照中,发现69种血浆代谢物与SCT相关,其中许多为eGFR标志物或氧化应激通路相关;64种可复制代谢物中25种(39%)在ARIC研究中得到复制。SCT相关代谢物可改善SCT个体发生ESKD的风险预测。

要点

  • 69种血浆代谢物与镰状细胞特质相关,多与eGFR或氧化应激相关。
  • 64种可复制代谢物中25种(39%)在ARIC研究中得到复制。
  • SCT相关代谢物可改善SCT个体ESKD风险预测。

核心结论

  • 鉴定并复制了与SCT相关的血浆代谢物,多与eGFR及SCD中改变的氧化应激、膜重塑通路相关。
  • 血浆代谢组学分析可能有助于SCT个体的ESKD风险分层。

研究设计与样本

  • 非靶向代谢组学(Metrolon Global Discovery Panel)检测851种基线血浆代谢物。
  • WHI研究中986名老年黑人女性SCT携带者(平均年龄61±7岁)与998名年龄和种族匹配的无SCT对照比较。
  • 复制在ARIC研究独立样本中进行,共1070名黑人男女性(含70名SCT携带者)。

主要发现

  • 年龄校正模型经多重检验校正后,69种代谢物与SCT显著相关。
  • 许多SCT相关代谢物为肾小球滤过标志物(eGFR)和/或与氧化应激代谢通路相关。
  • 64种可复制SCT相关代谢物中25种(39%)在ARIC研究中得到复制。
  • 在WHI的SCT个体中,纳入SCT相关代谢物较年龄+eGFR基线模型显著改善 incident ESKD 风险预测。

关键数值与推荐

  • WHI中SCT携带者平均年龄61±7岁。
  • 检测851种基线血浆代谢物。
  • 69种代谢物与SCT显著相关。
  • 64种可复制代谢物中25种(39%)在ARIC中复制。

临床怎么用

  • 血浆代谢组学分析可能有助于SCT个体的ESKD风险分层。
  • 需在更大队列中验证代谢物标志物的临床效用。

局限性

  • 需在更大队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: We identified 69 plasma metabolites associated with sickle cell trait, including markers of eGFR and/or related to oxidative stress pathways. Twenty-five percent or 39% of the sickle cell trait-associated metabolites were replicated in the Atherosclerosis Risk in Communities study. Sickle cell trait-associated metabolites individually or in aggregate were associated with better prediction of incident kidney failure in those with sickle cell trait. BACKGROUND: Sickle cell trait (SCT) is the heterozygous carrier state for sickle cell disease (SCD) and is common among individuals of African ancestry. Although SCT is a known risk factor for CKD and ESKD, the mechanisms underlying this phenotypic association have not been fully characterized. We used metabolomic profiling to gain insight into the pathobiology of SCT. METHODS: We used a nontargeted metabolomics approach (Metabolon Global Discovery Panel) to measure baseline plasma levels of 851 metabolites in 986 older Black women with SCT (mean age 61±7 years) compared with 998 age- and race-matched controls without SCT from the prospective Women's Health Initiative (WHI) study. Age-adjusted linear regression was used to assess the association between metabolite levels and SCT. Replication was performed in an independent sample of 1070 Black men and women (including 70 with SCT) from the Atherosclerosis Risk in Communities study. RESULTS: In age-adjusted models, 69 metabolites were significantly associated with SCT in WHI after correction for multiple testing. Many of the SCT-associated metabolites are markers of kidney glomerular filtration (eGFR) and/or related to oxidative stress metabolic pathways are known to be altered in SCD homozygotes. Of the 64 SCT-associated metabolites available for replication, 25 or 39% were replicated in the Atherosclerosis Risk in Communities study. Inclusion of SCT-associated metabolites was associated with significantly better risk prediction of incident ESKD in WHI among SCT individuals compared with a baseline model adjusted for age+eGFR. CONCLUSIONS: We identified and replicated metabolites associated with SCT, many of which are related to eGFR and/or pathways altered in SCD ( e.g ., oxidative stress, membrane remodeling). These results suggest that plasma metabolomic profiling may be useful in ESKD risk stratification for individuals with SCT, meriting validation in larger cohorts.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Cai Y, Surapaneni A, Vasconcelos AG, et al. Alterations of Plasma Metabolites Associated with Sickle Cell Trait. Clin J Am Soc Nephrol. 2026. PMID: 41758580. doi:10.2215/CJN.0000001015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。